Latest Tuberculosis treatment Stories

2009-03-31 14:21:42

British medical scientists say the discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria might lead to new anti-TB drugs. Until now it was thought that M. tuberculosis bacteria in the lungs of TB patients were rapidly multiplying. However recent research by Simon Waddell and colleagues from St George's University of London and the University of Leicester revealed the tuberculosis bacteria in the sputum of TB patients resemble bacteria that are growing very slowly or...

2009-03-23 12:20:00

The World Health Organization announced Monday in China, more money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat. An annual update on tuberculosis is being released by the World Health Organization on Tuesday, which is also World TB Day, an event meant to raise awareness of a disease that claims over 1.5 million people every year.  Close to 9 million people are infected in Africa and Asia. "Drug-resistant...

2009-03-23 08:00:00

Danya Presents Findings of Pilot Study at East African Health Conference in Kenya SILVER SPRING, Md., March 23 /PRNewswire/ -- Danya International, Inc. (Danya), a communications, research, and technology firm, will share the results of a pilot study on the effectiveness of mobile video-enabled phones in meeting the requirements for monitoring medication adherence by tuberculosis (TB) patients during the 3rd East African Health and Scientific Conference. The findings of the Mobile Direct...

2009-03-19 11:18:58

The U.S. tuberculosis rate fell to an all-time low of 4.2 cases per 100,000 people, or 12,898 new cases, in 2008, federal health officials said. However, the Centers for Disease Control and Prevention's Mortality and Morbidity Weekly Report said progress in eliminating TB hit a plateau in recent years, with a 3.8 percent average annual rate of decline for 2000-2008, compared to 7.3 percent for 1993-2000. TB continued to disproportionately affect racial and ethnic minorities and foreign-born...

2009-02-26 16:36:42

U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis, Reuters reported. Doctors say the combination of AstraZeneca's MERREM I.V., also called meropenem, and clavulanate, sold by GlaxoSmithKline in combination with amoxicillin as the drug Augmentin, killed laboratory-grown strains of TB in clinical trials. Researchers wrote in the journal Science that the combination worked in lab dishes...

2009-01-23 14:36:31

A four-month treatment with the drug rifampin is better tolerated for tuberculosis than the nine-month treatment of isoniazid, Canadian researchers said. Dr. Dick Menzies of the McGill University said patients who are infected with the latent form of TB show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. Patients who currently receive a diagnosis of latent TB are treated for nine months with daily doses of isoniazid;...

2009-01-22 14:36:12

MUHC researchers are studying a shorter treatment with fewer side effects Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. The latest study by Dr. Dick Menzies of the Research Institute of the McGill University Health Centre (MUHC) describes a new potential treatment for this particular form of TB. The paper based on this study was recently published in the...

2009-01-06 11:33:23

Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.In a study led by researchers at Johns Hopkins Children's Center, risks of drug...

2008-11-06 14:07:24

New research on drug-resistant tuberculosis found that the hard-to-treat disease results in death for half of patients who get it. South Korean researchers presented the study "“ one of few to track survival rates from the condition called extensively drug-resistant TB "“ in the latest edition of the American Journal of Respiratory and Critical Care Medicine. The study consisted of 1,407 patients who had either multidrug resistant TB, which is the most aggressive because it...

2008-10-30 06:00:44

Concert Pharmaceuticals, a biotechnology company, has announced encouraging findings from a preclinical study suggesting that C-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing. In the preclinical study, C-20081 had a 43% increase in plasma half-life compared to linezolid, which might allow for lower overall drug exposure and improved tolerability with a once-daily dose. Concert has evaluated the effect of selective...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'